Janssen’s teclistamab gets CMA from European Commission
Teclistamab is the first bispecific antibody worldwide to be approved for patients with relapsed and refractory multiple myeloma
Read More
Author: Emily Kimber
Alpha Cognition announces bioequivalence study results for Alzheimer’s
In 2019, there were over 850,000 people with dementia in the UK, representing one in every 14 people aged 65 and over
Read More
Trial results for Pfizer and BioNTech’s COVID-19 vaccine for children released
The phase 2/3 trial results showed that the vaccine was effective in protecting children
Read More
Roche launches digital PCR system for ultra-rare and emerging diseases
Using the system, the researchers are able to divide DNA and RNA from an already extracted clinical sample into as many as 100,000 microscopic individual reactions
Read More
